144 related articles for article (PubMed ID: 9825002)
41. HPV-based cervical cancer screening in a population at high risk for HIV infection.
Womack SD; Chirenje ZM; Gaffikin L; Blumenthal PD; McGrath JA; Chipato T; Ngwalle S; Munjoma M; Shah KV
Int J Cancer; 2000 Jan; 85(2):206-10. PubMed ID: 10629079
[TBL] [Abstract][Full Text] [Related]
42. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
[TBL] [Abstract][Full Text] [Related]
44. Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions.
Park TW; Richart RM; Sun XW; Wright TC
J Natl Cancer Inst; 1996 Mar; 88(6):355-8. PubMed ID: 8609644
[TBL] [Abstract][Full Text] [Related]
45. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.
Elfgren K; Bistoletti P; Dillner L; Walboomers JM; Meijer CJ; Dillner J
Am J Obstet Gynecol; 1996 Mar; 174(3):937-42. PubMed ID: 8633673
[TBL] [Abstract][Full Text] [Related]
46. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.
Madeddu G; Mameli G; Capobianco G; Babudieri S; Maida I; Bagella P; Rocca G; Cherchi PL; Sechi LA; Zanetti S; Nunnari G; Dessole S; Mura MS
Eur Rev Med Pharmacol Sci; 2014; 18(8):1277-85. PubMed ID: 24817305
[TBL] [Abstract][Full Text] [Related]
47. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania.
Mayaud P; Gill DK; Weiss HA; Uledi E; Kopwe L; Todd J; ka-Gina G; Grosskurth H; Hayes RJ; Mabey DC; Lacey CJ
Sex Transm Infect; 2001 Aug; 77(4):248-54. PubMed ID: 11463923
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso.
Didelot-Rousseau MN; Nagot N; Costes-Martineau V; Vallès X; Ouedraogo A; Konate I; Weiss HA; Van de Perre P; Mayaud P; Segondy M;
Br J Cancer; 2006 Aug; 95(3):355-62. PubMed ID: 16832413
[TBL] [Abstract][Full Text] [Related]
49. Follow-up of high-grade squamous intra-epithelial lesions (H-SIls) in human immunodeficiency virus (HIV)-positive and human papillomavirus (HPV)-positive women. analysis of risk factors.
Frega A; Biamonti A; Maranghi L; Vetrano G; Palazzo A; Iacovelli R; Corosu R; French D; Moscarini M; Vecchione A
Anticancer Res; 2006; 26(4B):3167-70. PubMed ID: 16886651
[TBL] [Abstract][Full Text] [Related]
50. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
[TBL] [Abstract][Full Text] [Related]
51. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.
Massad LS; Ahdieh L; Benning L; Minkoff H; Greenblatt RM; Watts H; Miotti P; Anastos K; Moxley M; Muderspach LI; Melnick S
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):432-42. PubMed ID: 11511819
[TBL] [Abstract][Full Text] [Related]
52. The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.
Minkoff H; Zhong Y; Strickler HD; Watts DH; Palefsky JM; Levine AM; D'Souza G; Howard AA; Plankey M; Massad LS; Burk R
Infect Dis Obstet Gynecol; 2008; 2008():587082. PubMed ID: 18437233
[TBL] [Abstract][Full Text] [Related]
53. The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.
Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J;
Am J Obstet Gynecol; 2001 Feb; 184(3):322-30. PubMed ID: 11228481
[TBL] [Abstract][Full Text] [Related]
54. Presence of human papillomavirus and Epstein-Barr virus in the cervix of women infected with the human immunodeficiency virus.
Ammatuna P; Giovannelli L; Giambelluca D; Mancuso S; Rubino E; Colletti P; Mazzola G; Belfiore P; Lima R
J Med Virol; 2000 Dec; 62(4):410-5. PubMed ID: 11074467
[TBL] [Abstract][Full Text] [Related]
55. [Squamous intra-epithelial lesions in HIV seropositive females. Their frequency and association with cervical neoplasia risk factors].
Suárez Rincón AE; Vázquez Valls E; Ramírez Rodríguez M; Montoya Fuentes H; Covarrubias Rodríguez Mde L; Sánchez Corona J
Ginecol Obstet Mex; 2003 Jan; 71():32-43. PubMed ID: 12708348
[TBL] [Abstract][Full Text] [Related]
56. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
Tsukui T; Hildesheim A; Schiffman MH; Lucci J; Contois D; Lawler P; Rush BB; Lorincz AT; Corrigan A; Burk RD; Qu W; Marshall MA; Mann D; Carrington M; Clerici M; Shearer GM; Carbone DP; Scott DR; Houghten RA; Berzofsky JA
Cancer Res; 1996 Sep; 56(17):3967-74. PubMed ID: 8752165
[TBL] [Abstract][Full Text] [Related]
57. Apoptosis-related proteins and cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women.
Spinillo A; Zara F; Zappatore R; Cesari S; Bergante C; Morbini P
Gynecol Oncol; 2004 Dec; 95(3):500-5. PubMed ID: 15581953
[TBL] [Abstract][Full Text] [Related]
58. Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16.
Ellis JR; Etherington I; Galloway D; Luesley D; Young LS
Lancet; 1997 Apr; 349(9058):1069-70. PubMed ID: 9107250
[No Abstract] [Full Text] [Related]
59. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women.
Krüger-Kjaer S; van den Brule AJ; Svare EI; Engholm G; Sherman ME; Poll PA; Walboomers JM; Bock JE; Meijer CJ
Int J Cancer; 1998 May; 76(5):613-9. PubMed ID: 9610715
[TBL] [Abstract][Full Text] [Related]
60. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
